Patient-first clinical trial design is a priority for research and development stakeholders in a post-pandemic era. Gathering intelligence about patient preferences and considerations can help shape ...

C-reactive protein (CRP) is gaining credibility as a prognostic factor in different cancers. Cox's proportional hazard (PH) model is usually used to assess prognostic factors. However, this model ...